Clinical Trial Update: TACE Study-Liver Embolization Perfusion (VGH Radiology LIU)

View source ↗

Summary

Clinical trial NCT02093104 on liver embolization perfusion (TACE) has completed, in patients with unresectable hepatocellular carcinoma undergoing chemoemboliza…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: University of British Columbia | Conditions: Unresectable Hepatocellular Carcinoma, Undergoing Chemoembolization and Radioembolization | Status: COMPLETED